BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27080192)

  • 1. Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy.
    Delaney M; Mayock D; Knezevic A; Norby-Slycord C; Kleine E; Patel R; Easley K; Josephson C
    Transfusion; 2016 Aug; 56(8):1945-50. PubMed ID: 27080192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study.
    Josephson CD; Caliendo AM; Easley KA; Knezevic A; Shenvi N; Hinkes MT; Patel RM; Hillyer CD; Roback JD
    JAMA Pediatr; 2014 Nov; 168(11):1054-62. PubMed ID: 25243446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
    Josephson CD; Castillejo MI; Caliendo AM; Waller EK; Zimring J; Easley KA; Kutner M; Hillyer CD; Roback JD
    Transfus Med Rev; 2011 Apr; 25(2):125-32. PubMed ID: 21345642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
    Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
    Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
    Weisberg SP; Staley EM; Williams LA; Pham HP; Bachegowda LS; Cheng YH; Schwartz J; Shaz BH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1705-1711. PubMed ID: 28849943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
    Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
    Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
    Wu Y; Zou S; Cable R; Dorsey K; Tang Y; Hapip CA; Melmed R; Trouern-Trend J; Wang JH; Champion M; Fang C; Dodd R
    Transfusion; 2010 Apr; 50(4):776-86. PubMed ID: 19912585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Institutional Policies for Provision of "CMV-Safe" Blood in Ontario.
    Finlay L; Nippak P; Tiessen J; Isaac W; Callum J; Cserti-Gazdewich C
    Am J Clin Pathol; 2016 Nov; 146(5):578-584. PubMed ID: 28430958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the risk of transfusion-transmitted cytomegalovirus infection: a systematic review and meta-analysis.
    Mainou M; Alahdab F; Tobian AA; Asi N; Mohammed K; Murad MH; Grossman BJ
    Transfusion; 2016 Jun; 56(6 Pt 2):1569-80. PubMed ID: 26826015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections.
    ; Heddle NM; Boeckh M; Grossman B; Jacobson J; Kleinman S; Tobian AA; Webert K; Wong EC; Roback JD
    Transfusion; 2016 Jun; 56(6 Pt 2):1581-7. PubMed ID: 26968400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study.
    Preiksaitis JK; Brown L; McKenzie M
    Transfusion; 1988; 28(3):205-9. PubMed ID: 2835838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.
    Shigemura T; Yanagisawa R; Komori K; Morita D; Kurata T; Tanaka M; Sakashita K; Nakazawa Y
    Transfusion; 2019 Oct; 59(10):3065-3070. PubMed ID: 31322734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
    Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
    Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
    Hall S; Danby R; Osman H; Peniket A; Rocha V; Craddock C; Murphy M; Chaganti S
    Transfus Med; 2015 Dec; 25(6):418-23. PubMed ID: 26114211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.
    Kim AR; Lee YK; Kim KA; Chu YK; Baik BY; Kim ES; Yun SC; Kim KS; Pi SY
    J Korean Med Sci; 2006 Feb; 21(1):5-10. PubMed ID: 16479056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
    Ziemann M; Juhl D; Görg S; Hennig H
    Transfusion; 2013 Oct; 53(10):2183-9. PubMed ID: 23581526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells.
    Luban NL; Williams AE; MacDonald MG; Mikesell GT; Williams KM; Sacher RA
    Am J Dis Child; 1987 Apr; 141(4):416-9. PubMed ID: 3031977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence analyses of variable cytomegalovirus genes for distinction between breast milk- and transfusion-transmitted infections in very-low-birth-weight infants.
    Furui Y; Yamagishi N; Morioka I; Taira R; Nishida K; Ohyama S; Matsumoto H; Nakamachi Y; Hasegawa T; Matsubayashi K; Nagai T; Satake M
    Transfusion; 2018 Dec; 58(12):2894-2902. PubMed ID: 30338856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.